Fission of Tubular Endosomes Triggers Endosomal Acidification and Movement
Overview
Affiliations
The early endosome acts as a sorting station for internalized molecules destined for recycling or degradation. While recycled molecules are sorted and delivered to tubular endosomes, residual compartments containing molecules to be degraded undergo "maturation" before final degradation in the lysosome. This maturation involves acidification, microtubule-dependent motility, and perinuclear localization. It is currently unknown how sorting and the processes of maturation cooperate with each other. Here, we show that fission of a tubular endosome triggers the maturation of the residual endosome, leading to degradation. Use of the dynamin inhibitor dynasore to block tubular endosome fission inhibited acidification, endosomal motility along microtubules, perinuclear localization, and degradation. However, tubular endosome fission was not affected by inhibiting endosomal acidification or by depolymerizing the microtubules. These results demonstrate that the fission of recycling tubules is the first important step in endosomal maturation and degradation in the lysosome. We believe this to be the first evidence of a cascade from sorting to degradation.
ARF1 compartments direct cargo flow via maturation into recycling endosomes.
Stockhammer A, Adarska P, Natalia V, Heuhsen A, Klemt A, Bregu G Nat Cell Biol. 2024; 26(11):1845-1859.
PMID: 39367144 PMC: 11567898. DOI: 10.1038/s41556-024-01518-4.
Membrane Tension Regulation is Required for Wound Repair.
Raj N, Weiss M, Vos B, Weischer S, Brinkmann F, Betz T Adv Sci (Weinh). 2024; 11(48):e2402317.
PMID: 39360573 PMC: 11672324. DOI: 10.1002/advs.202402317.
Kirby J, Standfest M, Binkley J, Barnes C, Brown E, Cairncross T J Appl Oral Sci. 2024; 32:e20240224.
PMID: 39356951 PMC: 11464084. DOI: 10.1590/1678-7757-2024-0224.
Joensuu M, Syed P, Saber S, Lanoue V, Wallis T, Rae J EMBO J. 2023; 42(13):e112095.
PMID: 37226896 PMC: 10308369. DOI: 10.15252/embj.2022112095.
Perez Bay A, Faulkner D, DaSilva J, Young T, Yang K, Giurleo J Mol Cancer Ther. 2023; 22(3):357-370.
PMID: 36861363 PMC: 9978886. DOI: 10.1158/1535-7163.MCT-22-0414.